LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 A443654
0.37
uM
LJP6
 0.3232 0.0935 0.0246 0.1180
BT-20 OSI-027
0.37
uM
LJP6
 0.6860 0.0573 0.5482 0.0758
BT-20 XMD11-85h
0.37
uM
LJP6
 0.9253 0.0708 0.8953 0.1006
BT-20 HG-6-64-01
0.37
uM
LJP6
 0.8588 0.1043 0.8013 0.1486
BT-20 WH-4-025
0.37
uM
LJP5
 0.7020 0.0272 0.5679 0.0406
BT-20 WZ-4-145
0.37
uM
LJP6
 0.8488 0.0819 0.7855 0.1153
BT-20 XMD16-144
0.37
uM
LJP5
 0.3612 0.0143 0.0739 0.0339
BT-20 Brivanib
0.37
uM
LJP5
 0.9787 0.0072 0.9693 0.0101
BT-20 Buparlisib
0.37
uM
LJP5
 0.6212 0.0520 0.4532 0.0669
BT-20 BX-912
0.37
uM
LJP5
 0.9652 0.0136 0.9491 0.0204
BT-20 Canertinib
0.37
uM
LJP6
 0.8459 0.0199 0.7778 0.0249
BT-20 Celastrol
0.37
uM
LJP6
 0.8739 0.0270 0.8187 0.0365
BT-20 CGP60474
0.37
uM
LJP5
 0.1911 0.0510 -0.1745 0.0939
BT-20 CGP60474
0.37
uM
LJP6
 0.1621 0.0177 -0.2152 0.0491
BT-20 CHIR-99021
0.37
uM
LJP6
 0.9470 0.0435 0.9246 0.0612
BT-20 CP724714
0.37
uM
LJP5
 0.9257 0.0227 0.8920 0.0328
BT-20 CP466722
0.37
uM
LJP5
 1.0270 0.0178 1.0389 0.0253
BT-20 Crizotinib
0.37
uM
LJP5
 0.8679 0.0028 0.8084 0.0072
BT-20 Momelotinib
0.37
uM
LJP5
 0.8799 0.0417 0.8267 0.0589
BT-20 Dasatinib
0.37
uM
LJP5
 0.3781 0.0175 0.0992 0.0218
BT-20 Dasatinib
0.37
uM
LJP6
 0.3486 0.0491 0.0587 0.0538
BT-20 Dovitinib
0.37
uM
LJP5
 0.5493 0.0623 0.3500 0.0789
BT-20 Enzastaurin
0.37
uM
LJP5
 1.0795 0.0224 1.1141 0.0311
BT-20 Erlotinib
0.37
uM
LJP5
 0.9311 0.0343 0.9021 0.0485
BT-20 Foretinib
0.37
uM
LJP5
 0.4516 0.0676 0.2026 0.1101